!-- notag -->
!-- notag -->
!-- notag -->
Press Releases - 2018 - Sanofi
Worldwide presence
English
English
français
Media
MMMM D, YYYY
Press Releases 2018
Home
Media
Press releases
2018
Press Releases - 2018
Facebook
Twitter
LinkedIn
Download the PDF version
2018-12-26
MMMM DD YYYY
Press releases
Sanofi: FDA Approves VAXELIS(TM), Sanofi and MSD's Pediatric Hexavalent Combination Vaccine
Download the PDF version
2018-12-19
MMMM DD YYYY
Press releases
Dengvaxia® vaccine approved for prevention of dengue in Europe
Download the PDF version
2018-12-18
MMMM DD YYYY
Press releases
Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq
Download the PDF version
2018-11-16
MMMM DD YYYY
Press releases
Sanofi: European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness
Download the PDF version
2018-11-11
MMMM DD YYYY
Press releases
Sanofi: ODYSSEY OUTCOMES investigators highlight at AHA that Praluent® (alirocumab) was associated with fewer deaths from any cause
Download the PDF version
2018-11-07
MMMM DD YYYY
Press releases
New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) cardiovascular outcomes trial
Download the PDF version
2018-11-06
MMMM DD YYYY
Press releases
FDA grants priority review for Dupixent® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis
Download the PDF version
2018-11-01
MMMM DD YYYY
Press releases
Sanofi and Denali Therapeutics to develop treatments for neurological and inflammatory diseases
Download the PDF version
2018-10-31
MMMM DD YYYY
Press releases
Sanofi Q3 2018 Performance Confirms Return to Growth
Download the PDF version
2018-10-19
MMMM DD YYYY
Press releases
Sanofi: FDA approves asthma indication for Dupixent® (dupilumab)
Download the PDF version
2018-10-19
MMMM DD YYYY
Press releases
Sanofi receives positive CHMP opinion for dengue vaccine
Download the PDF version
2018-10-16
MMMM DD YYYY
Press releases
Sanofi: Dupixent® (dupilumab) showed positive topline results in two Phase 3 trials of patients with chronic rhinosinusitis with nasal polyps
Download the PDF version
2018-10-01
MMMM DD YYYY
Press releases
Sanofi completes divestiture of Zentiva to Advent
Download the PDF version
2018-09-28
MMMM DD YYYY
Press releases
Sanofi : FDA approves Libtayo® (cemiplimab) as first and only treatment for advanced cutaneous squamous cell carcinoma
Download the PDF version
2018-09-28
MMMM DD YYYY
Press releases
Sanofi: Availability of the Pre-quarterly Results Communication
Download the PDF version
2018-09-15
MMMM DD YYYY
Press releases
Sanofi: Positive Phase 3 results presented for Dupixent® (dupilumab)
Download the PDF version
2018-09-13
MMMM DD YYYY
Press releases
Sanofi to refocus two global business units
Download the PDF version
2018-09-12
MMMM DD YYYY
Press releases
FDA to review supplemental Biologics License Application for Praluent® (alirocumab) Injection as potential treatment to reduce major adverse cardiovascular events
Download the PDF version
2018-09-04
MMMM DD YYYY
Press releases
Sanofi reaches civil settlement with US SEC
Download the PDF version
2018-09-03
MMMM DD YYYY
Press releases
Sanofi: Cablivi(TM) (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
Download the PDF version
2018-07-31
MMMM DD YYYY
Press releases
Online Availability of Sanofi Group's Half-Year Financial Report for 2018
Download the PDF version
2018-07-31
MMMM DD YYYY
Press releases
Sanofi: Q2 2018 Performance Positions Sanofi for New Growth Phase
Download the PDF version
2018-07-26
MMMM DD YYYY
Press releases
Sanofi Head of Human Resources Roberto Pucci to retire; Company names Caroline Luscombe to take over October 1st
Download the PDF version
2018-06-29
MMMM DD YYYY
Press releases
Sanofi: Availability of the Pre-quarterly Results Communication
Download the PDF version
2018-06-29
MMMM DD YYYY
Press releases
Sanofi: CHMP recommends approval of Cablivi(TM) (caplacizumab)
Download the PDF version
2018-06-28
MMMM DD YYYY
Press releases
Sanofi : Sanofi and Advent finalize negotiations for the acquisition of Zentiva
Download the PDF version
2018-06-19
MMMM DD YYYY
Press releases
Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer
Download the PDF version
2018-06-19
MMMM DD YYYY
Press releases
Sanofi : Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure
Download the PDF version
2018-06-13
MMMM DD YYYY
Press releases
Sanofi : Sanofi successfully prices USD 2 billion bond issue
Download the PDF version
2018-06-11
MMMM DD YYYY
Press releases
Sanofi Launches "Action 2018", a Worldwide Employee Stock Purchase Plan
Download the PDF version
2018-06-04
MMMM DD YYYY
Press releases
Sanofi: New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma
Download the PDF version
2018-05-21
MMMM DD YYYY
Press releases
Sanofi: New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma
Download the PDF version
2018-05-16
MMMM DD YYYY
Press releases
Sanofi: Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis
Download the PDF version
2018-05-14
MMMM DD YYYY
Press releases
Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period
Download the PDF version
2018-05-14
MMMM DD YYYY
Press releases
Sanofi and Ablynx Announce the Successful Results of the Initial Tender Offer Period for Ablynx and Commencement of Squeeze-Out Tender Period
Download the PDF version
2018-05-02
MMMM DD YYYY
Press releases
Sanofi: Annual General Shareholders' Meeting of May 2, 2018
Download the PDF version
2018-04-30
MMMM DD YYYY
Press releases
Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
Download the PDF version
2018-04-27
MMMM DD YYYY
Press releases
Sanofi: First-quarter 2018 Business EPS(1) up 1.4% at CER
Download the PDF version
2018-04-24
MMMM DD YYYY
Press releases
Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July 1
Download the PDF version
2018-04-17
MMMM DD YYYY
Press releases
Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi's European generics business
Download the PDF version
2018-04-12
MMMM DD YYYY
Press releases
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...
Download the PDF version
2018-04-12
MMMM DD YYYY
Press releases
Sanofi to invest €350 million in Canadian vaccine facility
Download the PDF version
2018-04-03
MMMM DD YYYY
Press releases
Sanofi: EMA to review Dupixent® (dupilumab) as potential treatment for inadequately controlled moderate-to-severe asthma
Download the PDF version
2018-04-03
MMMM DD YYYY
Press releases
Sanofi: EMA to review cemiplimab as a potential treatment for advanced cutaneous squamous cell carcinoma
Download the PDF version
2018-03-29
MMMM DD YYYY
Press releases
Sanofi: EMA to review sotagliflozin as potential treatment for type 1 diabetes
Download the PDF version
2018-03-29
MMMM DD YYYY
Press releases
Previously announced Tender Offers by Sanofi to acquire Ablynx will commence on April 4, 2018
Download the PDF version
2018-03-28
MMMM DD YYYY
Press releases
Sanofi: Availability of the Pre-quarterly Results Communication
Download the PDF version
2018-03-15
MMMM DD YYYY
Press releases
Sanofi successfully prices EUR 8 billion of bond issues
Download the PDF version
2018-03-10
MMMM DD YYYY
Press releases
Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health risk and unmet need
Download the PDF version
2018-03-10
MMMM DD YYYY
Press releases
Sanofi: Praluent® (alirocumab) significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate
Download the PDF version
2018-03-08
MMMM DD YYYY
Press releases
Sanofi Completes Acquisition of Bioverativ Inc.
Download the PDF version
2018-03-08
MMMM DD YYYY
Press releases
Evotec and Sanofi in exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform
Download the PDF version
2018-03-07
MMMM DD YYYY
Press releases
Sanofi: Filing of the 2017 U.S. Form 20-F and French « Document de Référence » containing the Annual Financial Report
Download the PDF version
2018-03-06
MMMM DD YYYY
Press releases
Sanofi's Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director
Download the PDF version
2018-03-02
MMMM DD YYYY
Press releases
Sanofi : FDA to review Dupixent® (dupilumab) as potential treatment for moderate-to-severe asthma
Download the PDF version
2018-03-01
MMMM DD YYYY
Press releases
Sanofi Announces Receipt of Antitrust Clearances in Connection with the Acquisition of Ablynx
Download the PDF version
2018-02-23
MMMM DD YYYY
Press releases
Sanofi: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Bioverativ
Download the PDF version
2018-02-08
MMMM DD YYYY
Press releases
Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc.
Download the PDF version
2018-02-07
MMMM DD YYYY
Press releases
Sanofi Delivers 2017 Business EPS(1) in line with Guidance
Download the PDF version
2018-01-31
MMMM DD YYYY
Press releases
Sanofi: Sanofi, DNDi seek European Medicines Agency review for sleeping sickness treatment
Download the PDF version
2018-01-29
MMMM DD YYYY
Press releases
Sanofi to acquire Ablynx for €3.9 Billion
Download the PDF version
2018-01-23
MMMM DD YYYY
Press releases
Sanofi: Availability of the Pre-quarterly Results Communication
Download the PDF version
2018-01-22
MMMM DD YYYY
Press releases
Sanofi to Acquire Bioverativ for $11.6 Billion
Download the PDF version
2018-01-19
MMMM DD YYYY
Press releases
Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee
Download the PDF version
2018-01-08
MMMM DD YYYY
Press releases
Sanofi and Regeneron to accelerate and expand investment for cemiplimab and dupilumab development programs
Download the PDF version
2018-01-07
MMMM DD YYYY
Press releases
Sanofi and Alnylam enter into strategic restructuring of RNAi therapeutics rare disease alliance
!-- notag -->